AKT1 and cancer: Meng et al. found that UA boosted the anti-cancer effects of paclitaxel (PTX) in esophageal squamous cell carcinoma by inhibiting the Akt/FOXM1 cascade, leading to increased cell death and reduced cell mobility (Meng et al., 2021).